Aviva
HOLX

Aviva’s Hologic HOLX Stock Holding History

Aviva’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-191,643
Closed -$14.5M – 881
2026
Q1 		$14.5M Buy
191,643
+4,741
+3% +$356K 0.02% 466
2025
Q4 		$13.9M Buy
186,902
+9,509
+5% +$695K 0.02% 485
2025
Q3 		$12M Buy
177,393
+10,381
+6% +$689K 0.02% 496
2025
Q2 		$10.9M Buy
167,012
+8,460
+5% +$507K 0.02% 504
2025
Q1 		$9.79M Buy
158,552
+17,663
+13% +$1.17M 0.02% 458
2024
Q4 		$10.2M Sell
140,889
-120,491
-46% -$9.41M 0.03% 437
2024
Q3 		$21.3M Buy
261,380
+6,501
+3% +$520K 0.06% 333
2024
Q2 		$18.9M Buy
254,879
+55,103
+28% +$4.13M 0.05% 356
2024
Q1 		$15.6M Sell
199,776
-17,009
-8% -$1.27M 0.05% 385
2023
Q4 		$15.5M Sell
216,785
-26,084
-11% -$1.82M 0.06% 374
2023
Q3 		$16.9M Buy
242,869
+20,122
+9% +$1.52M 0.07% 349
2023
Q2 		$18M Sell
222,747
-328,805
-60% -$26.9M 0.07% 335
2023
Q1 		$44.5M Buy
551,552
+204,702
+59% +$16.5M 0.2% 111
2022
Q4 		$25.9M Buy
346,850
+58,795
+20% +$4.19M 0.13% 213
2022
Q3 		$18.6M Buy
288,055
+65,564
+29% +$4.54M 0.11% 257
2022
Q2 		$15.4M Buy
222,491
+146,948
+195% +$10.9M 0.08% 336
2022
Q1 		$5.8M Buy
75,543
+513
+0.7% +$36.9K 0.03% 566
2021
Q4 		$5.74M Sell
75,030
-66,650
-47% -$4.9M 0.02% 549
2021
Q3 		$10.5M Buy
141,680
+57,198
+68% +$4.29M 0.05% 382
2021
Q2 		$5.64M Sell
84,482
-1,919
-2% -$128K 0.02% 560
2021
Q1 		$6.43M Sell
86,401
-1,143
-1% -$86.8K 0.03% 462
2020
Q4 		$6.38M Buy
87,544
+4,876
+6% +$344K 0.03% 436
2020
Q3 		$5.5M Sell
82,668
-3,337
-4% -$211K 0.03% 426
2020
Q2 		$4.9M Sell
86,005
-6,276
-7% -$308K 0.03% 432
2020
Q1 		$3.24M Sell
92,281
-39,280
-30% -$1.87M 0.02% 643
2019
Q4 		$6.87M Buy
131,561
+37,162
+39% +$1.85M 0.04% 376
2019
Q3 		$4.77M Sell
94,399
-4,015
-4% -$198K 0.03% 438
2019
Q2 		$4.73M Sell
98,414
-2,095
-2% -$96.9K 0.03% 466
2019
Q1 		$4.87M Sell
100,509
-1,227
-1% -$55.3K 0.03% 464
2018
Q4 		$4.18M Sell
101,736
-30,246
-23% -$1.24M 0.03% 480
2018
Q3 		$5.41M Sell
131,982
-6,260
-5% -$253K 0.03% 521
2018
Q2 		$5.5M Sell
138,242
-1,456
-1% -$56K 0.03% 492
2018
Q1 		$5.22M Sell
139,698
-14,449
-9% -$584K 0.03% 505
2017
Q4 		$6.59M Sell
154,147
-22,306
-13% -$890K 0.04% 463
2017
Q3 		$6.48M Buy
176,453
+1,540
+0.9% +$62.2K 0.03% 486
2017
Q2 		$7.94M Buy
174,913
+1,660
+1% +$73.3K 0.04% 425
2017
Q1 		$7.37M Sell
173,253
-9,268
-5% -$378K 0.04% 438
2016
Q4 		$7.33M Buy
182,521
+11,679
+7% +$451K 0.04% 430
2016
Q3 		$6.64M Buy
170,842
+2,666
+2% +$101K 0.04% 464
2016
Q2 		$5.82M Buy
168,176
+24,162
+17% +$837K 0.04% 470
2016
Q1 		$4.97M Buy
144,014
+2,624
+2% +$91.5K 0.04% 488
2015
Q4 		$5.47M Sell
141,390
-40
-0% -$1.56K 0.04% 459
2015
Q3 		$14.2M Buy
+141,430
New +$5.61M 0.12% 200

Other funds holding HOLX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Aviva's HOLX Position: Q2 2026 in Review

Aviva sold out of Hologic (HOLX) in Q2 2026, closing a stake of 191,643 shares — an estimated $14.5M sold.

Aviva first reported a position in HOLX in Q3 2015 and held it in 43 quarters. The position peaked at $44.5M in Q1 2023. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Aviva reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Aviva sold 191,643 Hologic shares in Q2 2026, an estimated $14.5M.
  • Aviva first reported a position in Hologic in Q3 2015 and held it in 43 quarters.
  • Aviva's Hologic position peaked at $44.5M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.